Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123148) titled 'Comparison of the application effect of different doses of dexmedetomidine combined with hydromorphone in postoperative analgesia of lung cancer' on April 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shifang people's Hospital
Condition:
Postoperative pain in lung cancer patients
Intervention:
Low dose dexmedetomidine combined with hydromorphone group (D1 group):Analgesic pump drug: Dexmedetomidine 1 µ g/kg+hydromorphone 50 µ g/kg diluted to 100ml with normal saline
Medium dose dexmedetomidine combined with hydromorphone group (D2 group):Analgesic pump drug: Dexmedeto...